Journal of Cardiovascular Pharmacology

Empagliflozin Reduces Post-Myocardial Infarction Inflammation via BDH1/β-Hydroxybutyrate-Mediated NF-κB Modulation in Macrophages and the Heart

By Ji'e Yang, Ke Meng, Guohong Wu, Junbo Ge

Experiments in animalsInterventions

The paper

Ji'e Yang, Ke Meng, Guohong Wu, Junbo Ge

University of Science and Technology of China

Journal of Cardiovascular Pharmacology, 12 Aug 2026

doi.org/10.1097/fjc.0000000000001870 PubMed 42586056

Journal of Molecular and Cellular Cardiology2 Oct 2026
Persistent IFN-γ links to worse cardiac remodeling in aged mice
Experimental Gerontology8 Oct 2026
Ketogenic diet improved heart function in aged mice
International Immunopharmacology3 Oct 2026
Rapamycin improves efferocytosis and reduces plaques in mice